Study of a Smart Sharps Disposal Device in Patients With Hemophilia
ConditionHemophilia A and B
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania
About this trial
This pilot study will have patients use a smart sharps disposal container at home for disposal of needles used to administer their hemophilia drugs. The study aims to find out if the smart sharps container proved acceptable to use by patients and medical providers and can be adhered to.
Eligibility criteria
Qualifiers
Male or female, ≥18 years of age
Moderate or Severe Hemophilia A or B, with or without an inhibitor
Prescribed prophylaxis with either a factor product or emicizumab that is scheduled to be given at least once every 14 days
Stated inability to use the SharpsCue container
Disqualifiers
None
Trial design
Treatments tested in this trial
- The smart Sharps device is given to the patient and they use it to throw needles away in. It is not internal to the patient.
Treatment groups
23 Participants
are divided into 1 treatment groupSponsors and collaborators
University of Pennsylvania
Lead sponsor
Sharpscue
Collaborator
Source ClinicalTrials.gov